Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study
Cancers · 09.04.2026 · 18 (8) · 1200
DOI: 10.3390/cancers18081200 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 09.04.2026. Verfasst von Manuel Ramanović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Institute of Oncology Ljubljana, Zaloška cesta 2, SI-1000 Ljubljana, Slovenia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Total neoadjuvant therapy (TNT), integrating systemic chemotherapy and radiotherapy before surgery or surveillance, has become a standard approach for locally advanced rectal cancer (LARC). However, optimal sequencing strategies and long-term outcomes of watch-and-wait (W&W) following sandwich TNT remain insufficiently characterized. We evaluated oncologic outcomes and treatment response in patients treated with an institutional sandwich TNT protocol.
Methods
We conducted a retrospective cohort study of consecutive patients with LARC treated with sandwich TNT (induction chemotherapy followed by hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost [IMRT-SIB] chemoradiotherapy and consolidation chemotherapy) at the Institute of Oncology Ljubljana between 2016 and 2023. The primary endpoint was an overall complete response (CR; pathological [pCR] and clinical [cCR]). Secondary endpoints included tumor regression grade (TRG), major pathological response (MPR), R0 resection rate, organ preservation, overall survival (OS), and disease-free survival (DFS).
Results
Among 205 patients (median age 61 years), overall CR was 29.5% (pCR 19.3% and cCR 10.2%). Major pathological response (TRG 3–4) occurred in 37.6%. R0 resection was achieved in 94.5%. In the W&W cohort (n = 21), local regrowth occurred in 33.3% (95% CI, 14.6–57.0%) over a median follow-up of 4.96 years. Total mesorectal excision (TME)-free survival at 5 years was 73.1% (95% CI, 55.0–97.2%). Estimated 5-year OS was 81.1% (95% CI, 75.5–87.2%) and 5-year DFS was 75.2% (95% CI, 69.0–82.0). In multivariable analysis, non-R0 resection (HR 6.06, 95% CI, 1.99–18.42), MRI circumferential resection margin positivity (HR 3.11, 95% CI, 1.53–6.33), and MRI extramural vascular invasion positivity (HR 1.97, 95% CI, 1.05–3.91) remained independent predictors of DFS.
Conclusions
Institutional sandwich TNT yields meaningful tumor response and durable survival in MRI-defined high-risk LARC. Structured W&W offers organ preservation with acceptable oncologic control under intensive surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Institute of Oncology Ljubljana, Zaloška cesta 2, SI-1000 Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Kongresni trg 12, SI-1000 Ljubljana, Slovenia.
ORCID-Profile: Manuel Ramanović, Vaneja Velenik
Zitieren
APA
Ramanović, M., Anderluh, F., Peressutti, A. J., Korošec, P., Oblak, I., Šečerov Ermenc, A., & Velenik, V. (2026). Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study. Cancers, 18(8), 1200. https://doi.org/10.3390/cancers18081200
Vancouver
Ramanović M, Anderluh F, Peressutti AJ, Korošec P, Oblak I, Šečerov Ermenc A, et al. Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study. Cancers. 2026;18(8):1200. doi:10.3390/cancers18081200
BibTeX
@article{Ramanovi2026,
author = {Ramanović, Manuel and Anderluh, Franc and Peressutti, Ana Jeromen and Korošec, Petar and Oblak, Irena and Šečerov Ermenc, Ajra and Velenik, Vaneja},
title = {Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study},
journal = {Cancers},
year = {2026},
volume = {18},
number = {8},
pages = {1200},
doi = {10.3390/cancers18081200}
}
EUVIMED